(Q35847694)

English

Long-term outcome of individuals with pure red cell aplasia and antierythropoietin antibodies in patients treated with recombinant epoetin: a follow-up report from the Research on Adverse Drug Events and Reports (RADAR) Project

scientific article published on 11 August 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16099877%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Long-term outcome of individuals with pure red cell aplasia and antierythropoietin antibodies in patients treated with recombinant epoetin: a follow-up report from the Research on Adverse Drug Events and Reports (RADAR) Project (English)

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16099877%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Stefano Luminari

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16099877%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

6

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16099877%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Steven M. Belknap

8

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16099877%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

author name string

Charles L Bennett

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16099877%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Denis Cournoyer

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16099877%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Kenneth R Carson

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16099877%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Jerome Rossert

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16099877%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Francesco Locatelli

7

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16099877%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

June M McKoy

9

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16099877%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

E Alison Lyons

10

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16099877%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Benjamin Kim

11

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16099877%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Rishi Sharma

12

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16099877%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Stacey Costello

13

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16099877%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Edwin B Toffelmire

14

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16099877%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

George A Wells

15

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16099877%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Hans A Messner

16

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16099877%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Paul R Yarnold

17

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16099877%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Steven M Trifilio

18

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16099877%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Dennis W Raisch

19

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16099877%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Timothy M Kuzel

20

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16099877%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Allen Nissenson

21

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16099877%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Lay-Cheng Lim

22

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16099877%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Nicole Casadevall

24

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16099877%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Martin S Tallman

23

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16099877%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

language of work or name

0 references

publication date

11 August 2005

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16099877%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16099877%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

106

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16099877%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

10

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16099877%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

3343-3347

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16099877%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

The Research on Adverse Drug Events and Reports (RADAR) project.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895064

11 July 2018

Importance of biologic follow-ons: experience with EPO.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895064

11 July 2018

Recommendations on haematological criteria for the diagnosis of epoetin-induced pure red cell aplasia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895064

11 July 2018

Anti-erythropoietin antibodies and pure red cell aplasia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895064

11 July 2018

Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895064

11 July 2018

Mimicry of erythropoietin by a nonpeptide molecule

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895064

11 July 2018

Functional mimicry of a protein hormone by a peptide agonist: the EPO receptor complex at 2.8 A

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895064

11 July 2018

Recovery from anti-recombinant-human-erythropoietin associated pure red cell aplasia in end-stage renal disease patients after renal transplantation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895064

24 September 2018

Development and evaluation of a new ELISA for the detection and quantification of antierythropoietin antibodies in human sera

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895064

24 September 2018

Re-challenging patients who developed pure red cell aplasia with epoetin: can it be done?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895064

24 September 2018

Anti-erythropoietin antibody-mediated pure red cell aplasia after treatment with recombinant erythropoietin products: recommendations for minimization of risk.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895064

24 September 2018

Pure red-cell aplasia and epoetin therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895064

24 September 2018

Prolonged course of pure red cell aplasia after erythropoietin therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895064

24 September 2018

Pure red cell aplasia secondary to epoetin alpha responding to Darbepoetin alpha in a patient on peritoneal dialysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895064

24 September 2018

A cross-sectional immunosurveillance study of anti-EPO antibody levels in CRF patients receiving epoetin alfa in 5 Ontario Renal Centers.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895064

24 September 2018

Successful re-introduction of recombinant human erythropoietin following antibody induced pure red cell aplasia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895064

24 September 2018

Four cases of pure red cell aplasia secondary to epoetin beta, with strong temporal relationships.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895064

24 September 2018

High prevalence in Switzerland of pure red-cell aplasia due to anti-erythropoietin antibodies in chronic dialysis patients: report of five cases.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895064

24 September 2018

Treatment of erythropoietin-induced pure red cell aplasia: a retrospective study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895064

24 September 2018

Two haemodialysis patients with epoetin alfa-induced pure red-cell aplasia recovered despite treatment with another epoetin preparation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895064

24 September 2018

The detection of anti-erythropoietin antibodies in human serum and plasma. Part I. Validation of the protocol for a radioimmunoprecipitation assay.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895064

24 September 2018

New technologies for the detection of antibodies to therapeutic proteins.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895064

24 September 2018

Antibodies against rHuEPO: native and recombinant

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895064

24 September 2018

Subcutaneous compared with intravenous epoetin in patients receiving hemodialysis. Department of Veterans Affairs Cooperative Study Group on Erythropoietin in Hemodialysis Patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895064

24 September 2018

Antibodies against recombinant human erythropoietin in a patient with erythropoietin-resistant anemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/16099877

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antibodies to recombinant human erythropoietin causing pure red cell aplasia

1 reference

https://pubmed.ncbi.nlm.nih.gov/16099877

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Subcutaneous erythropoietin therapy: efficacy and economic implications

1 reference

https://pubmed.ncbi.nlm.nih.gov/16099877

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Potential cost savings of erythropoietin administration in end-stage renal disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/16099877

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Switching from i.v. to s.c. epoetin in hemodialysis patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/16099877

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pure red cell aplasia secondary to treatment with erythropoietin

1 reference

https://pubmed.ncbi.nlm.nih.gov/16099877

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of methods to detect and characterize antibodies against recombinant human erythropoietin

1 reference

https://pubmed.ncbi.nlm.nih.gov/16099877

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1182/BLOOD-2005-02-0508

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16099877%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16099877%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16099877%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35847694&oldid=1522992235"